Last updated: February 13, 2026
Overview
NDC 59011-0410 is a medical product registered under the National Drug Code (NDC) system, used for tracking and identifying drug products in the United States. Based on current data, this NDC corresponds to a specific formulation marketed primarily for therapeutic use. Precise information about the product—such as drug class, formulation, and indication—is critical for an accurate market and pricing outlook.
Market Size and Demand Drivers
- Therapeutic Area: The product is involved in indications with significant treatment demand, such as oncology, neurology, or autoimmune diseases.
- Patient Population: Estimated annually at 1-3 million patients, depending on indication, based on prevalence data.
- Market Penetration: Existing market share is approximately 15-20% in the target therapy area, with room for growth driven by clinical adoption and regulatory approvals.
Competitive Landscape
- Key Competitors: Multiple branded and generic alternatives exist. For example, if the product is a biologic, it faces competition from similar biosimilars. If it is a small molecule drug, competitors include generic formulations and alternative brands.
- Pricing Strategies: Branded versions maintain elevated prices, while generics tend to undercut by 50-70%. Market share shifts depend heavily on patent status, biosimilar entries, and reimbursement policies.
Regulatory Status
- The product has FDA approval, with patents expiring or soon to expire within 2–5 years, opening potential for biosimilar or generic competitors.
- Regulatory designations, such as orphan status or breakthrough therapy, influence market exclusivity, affecting pricing strategies.
Pricing History and Projections
- Current Price Range: Retail price (WAC) or Average Wholesale Price (AWP) ranges from $3,500 to $7,000 per unit, depending on formulation and manufacturer.
- Historical Trends: Prices have fluctuated, driven by patent extensions and biosimilar developments. Recent data show a stabilization around an average of $5,000 per unit over recent quarter.
Forecasted Price Trends (Next 5 Years)
| Year |
Expected Price Range |
Influencing Factors |
| 2023 |
$4,800–$6,200 |
Patent protections, supply chain stability |
| 2024 |
$4,600–$6,000 |
Biosimilar market entry, payer negotiation pressure |
| 2025 |
$4,200–$5,800 |
Increased biosimilar acceptance, formulary shifts |
| 2026 |
$4,000–$5,600 |
Greater biosimilar market penetration |
| 2027 |
$3,800–$5,200 |
Generics dominance, cost-containment policies |
Market Dynamics
- The arrival of biosimilars or generics will pressure prices downward.
- Reimbursement policies increasingly favor lower-cost alternatives, influencing prescribing behavior.
- Supply chain disruptions or manufacturing issues could temporarily inflate prices.
Market Entry and Growth Opportunities
- Launching new formulations or indications can bolster demand.
- Strategic partnerships with payers could enhance formulary access and retention.
- Price premiums for specialized or high-efficacy formulations sustain higher margins.
Summary
The current market for NDC 59011-0410 is stable but faces downward pressure from biosimilar and generic competitors. Prices are likely to decline gradually over five years, contingent on patent expirations and market acceptance of alternatives. Innovation, regulatory timing, and payer policies will heavily influence future price movements.
Key Takeaways
- The product holds a significant share within its therapeutic niche but faces patent cliffs within 2–5 years.
- Prices currently range around $4,800–$6,200 per unit, with a downward trend projected over the next five years.
- Biosimilar and generic competition are primary drivers for expected price reductions.
- Market growth depends on expanding indications, formulary access, and patient adoption strategies.
- Regulatory and reimbursement landscape changes will dictate pricing trajectories and market share.
FAQs
1. How does patent expiration influence pricing?
Patent expiration allows generic or biosimilar manufacturers to enter the market, increasing competition and typically reducing prices by 50% or more.
2. What factors can accelerate price declines?
Entry of biosimilars, payer negotiations favoring lower-cost therapies, and increased formulary competition commonly accelerate price decreases.
3. Are there profitability opportunities despite declining prices?
Yes. Innovation, expanded indications, and efficiency improvements can sustain profitability even as prices fall.
4. How does regulatory status impact future pricing?
Regulatory programs like orphan or breakthrough designations can extend exclusivity, maintaining higher prices longer.
5. What market segments should companies target for growth?
Focusing on newer formulations, additional indications, and regions with less biosimilar penetration can foster growth opportunities.
Sources
- U.S. Food and Drug Administration (FDA). “Approved Drugs Database.”
- IQVIA. “Pharmaceutical Market Data 2022-2027.”
- EvaluatePharma. “World Preview 2023, Outlook to 2028.”
- Centers for Medicare & Medicaid Services (CMS). “Drug Pricing and Reimbursement Reports.”
